These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 576306)

  • 41. [Kidney hypertrophy-hyperfunction correlation in rapid onset infantile-juvenile diabetes mellitus].
    Garciá Puig J; Mateos Antón F; Grande C; Pallardo LF; Gaspar G; Lesmes A; Cerdán A; Arnalich F; Anciones B; Gil Aguado A; Vázquez JJ; Montero A
    Rev Clin Esp; 1980 Dec; 159(6):389-92. PubMed ID: 7221105
    [No Abstract]   [Full Text] [Related]  

  • 42. Lipoprotein(a) and atherosclerotic disease in insulin-dependent diabetic patients with declining glomerular filtration rate.
    Earle KA; Mattock M; Morocutti A; Aravanitis D; Viberti GC
    Diabet Med; 1996 Dec; 13(12):1071-2. PubMed ID: 8973890
    [No Abstract]   [Full Text] [Related]  

  • 43. MicroRNAs 1915-3p, 2861, and 4532 Are Associated with Long-Term Renal Function Decline in Type 1 Diabetes.
    Monteiro MB; Santos-Bezerra DP; Pelaes TS; Vaidya VS; Corrêa-Giannella ML
    Clin Chem; 2019 Nov; 65(11):1458-1459. PubMed ID: 31427290
    [No Abstract]   [Full Text] [Related]  

  • 44. [Predicting diabetic nephropathy].
    Mogensen CE; Christensen CK
    Journ Annu Diabetol Hotel Dieu; 1984; ():333-49. PubMed ID: 6399537
    [No Abstract]   [Full Text] [Related]  

  • 45. Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated Type 1 diabetes.
    Cherney DZ; Sochett EB; Dekker MG; Perkins BA
    Diabet Med; 2010 Dec; 27(12):1358-65. PubMed ID: 21059087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation of preoperative renal function and identification of risk factors for eventual native renal failure in cyclosporine-treated nonuremic diabetic recipient of pancreas transplants alone.
    Wang YL; Stevens RB; Fioretto P; Lokeh A; Kunjummen D; Gruessner A; Schmidt WJ; Moudry-Munns KC; Mauer SM; Steffes MW
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1291-2. PubMed ID: 8442116
    [No Abstract]   [Full Text] [Related]  

  • 47. Pathophysiology of diabetic nephropathy.
    Sego S
    Nephrol Nurs J; 2007; 34(6):631-3. PubMed ID: 18203571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural involvement in type 1 and type 2 diabetic nephropathy.
    Dalla Vestra M; Saller A; Bortoloso E; Mauer M; Fioretto P
    Diabetes Metab; 2000 Jul; 26 Suppl 4():8-14. PubMed ID: 10922968
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myogenic tone and small artery remodelling: insight into diabetic nephropathy.
    Khavandi K; Greenstein AS; Sonoyama K; Withers S; Price A; Malik RA; Heagerty AM
    Nephrol Dial Transplant; 2009 Feb; 24(2):361-9. PubMed ID: 19028754
    [No Abstract]   [Full Text] [Related]  

  • 50. Long-term quality of life in diabetic patients after combined pancreas-kidney transplantation or kidney transplantation.
    Nakache R; Tyden G; Groth CG
    Transplant Proc; 1994 Apr; 26(2):510-1. PubMed ID: 8171529
    [No Abstract]   [Full Text] [Related]  

  • 51. Diabetic nephropathy: has the time come to move beyond plasma creatinine?
    Osman MM; Ahmed MH
    Ren Fail; 2006; 28(6):525-6. PubMed ID: 16928625
    [No Abstract]   [Full Text] [Related]  

  • 52. Studies of cardiovascular and renal function in subclinical and manifest diabetic nephropathy.
    Berglund J
    Acta Med Scand Suppl; 1988; 722():1-69. PubMed ID: 3163465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accounting for body composition does not improve cystatin C estimation of GFR in diabetic subjects with CKD.
    Rigalleau V; Raffaitin C; Gin H; Beauvieux MC; Le Moigne F; Lasseur C; Chauveau P; Combe C; Barthe N
    Am J Kidney Dis; 2007 Apr; 49(4):560; author reply 561. PubMed ID: 17386325
    [No Abstract]   [Full Text] [Related]  

  • 54. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate.
    Astrup AS; Tarnow L; Pietraszek L; Schalkwijk CG; Stehouwer CD; Parving HH; Rossing P
    Diabetes Care; 2008 Jun; 31(6):1170-6. PubMed ID: 18332153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diabetes: bardoxolone improves kidney function in type 2 diabetes.
    Thomas MC; Cooper ME
    Nat Rev Nephrol; 2011 Aug; 7(10):552-3. PubMed ID: 21862993
    [No Abstract]   [Full Text] [Related]  

  • 56. American Diabetes Association scientific sessions, 1995.
    Bloomgarden ZT
    Diabetes Care; 1995 Oct; 18(10):1402-5. PubMed ID: 8721950
    [No Abstract]   [Full Text] [Related]  

  • 57. Management of diabetes in patients with end-stage kidney disease.
    Zuber K
    JAAPA; 2012 Nov; 25(11):26-9. PubMed ID: 23620920
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus.
    Kearns PJ
    JPEN J Parenter Enteral Nutr; 1991; 15(6):685-6. PubMed ID: 1766061
    [No Abstract]   [Full Text] [Related]  

  • 59. Mechanisms of diabetic hyperfiltration.
    Bank N
    Kidney Int; 1991 Oct; 40(4):792-807. PubMed ID: 1745032
    [No Abstract]   [Full Text] [Related]  

  • 60. Genesis and evolution of diabetic nephropathy.
    Keen H; Viberti GC
    J Clin Pathol; 1981 Nov; 34(11):1261-6. PubMed ID: 7320223
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.